{"title":"John Carreyrou","description":"\u003cp\u003eJohn Carreyrou’s gripping narratives unravel true stories of deception and corporate intrigue, immersing readers in the tense world of crime and thriller. His investigative style offers a compelling look at the dark underbelly of high-stakes business scandals, blending meticulous research with vivid storytelling.\u003c\/p\u003e\n\n\u003cp\u003eBeyond the thrill, Carreyrou’s work also provides insightful \u003cem\u003elessons in resilience and integrity\u003c\/em\u003e, appealing to those interested in self-help and personal development. His books explore how truth and perseverance can prevail against formidable odds, inspiring readers to navigate challenges with courage and clarity.\u003c\/p\u003e","products":[{"product_id":"bad-blood","title":"Bad Blood","description":"\u003cdiv class=\"book-description\"\u003e\n\u003cp\u003eNow with a new afterword covering the months-long landmark trials of Elizabeth Holmes and Sunny Balwani.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003e'I couldn't put down this thriller . . . the perfect book to read by the fire this winter.'\u003c\/em\u003e – Bill Gates\u003c\/p\u003e\n\n\u003cp\u003eWinner of the Financial Times\/McKinsey Business Book of the Year Award 2018\u003c\/p\u003e\n\n\u003cp\u003eThe riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.\u003c\/p\u003e\n\n\u003cp\u003eIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionise the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work.\u003c\/p\u003e\n\n\u003cp\u003eIn \u003cem\u003eBad Blood\u003c\/em\u003e, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003e'Chilling . . . Reads like a West Coast version of All the President's Men.'\u003c\/em\u003e – New York Times Book Review\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Macmillan Publishing Services","offers":[{"title":"Default Title","offer_id":45779640090860,"sku":"9781035006779","price":27.99,"currency_code":"NZD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0705\/7784\/8556\/files\/9781035006779.jpg?v=1727601087"},{"product_id":"bad-blood-by-john-carreyrou-9780525431992","title":"Bad Blood","description":"\u003cdiv class=\"book-description\"\u003e\n\u003cp\u003e\u003cem\u003eNational Best Seller\u003c\/em\u003e • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new afterword covering her trial and sentencing, bringing the story to a close.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003e“Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” —The New York Times Book Review\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003eIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup unicorn promised to revolutionise the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood.\u003c\/p\u003e\n\n\u003cp\u003eBacked by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Penguin Random House NZ","offers":[{"title":"Default Title","offer_id":47642781614316,"sku":"9780525431992","price":55.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0705\/7784\/8556\/files\/9780525431992-bad-blood.jpg?v=1779157684"}],"url":"https:\/\/bookhero.pro\/collections\/john-carreyrou.oembed","provider":"Book Hero","version":"1.0","type":"link"}